What is the recommended dose of cryoprecipitate (Cryoprecipitated Antihemophilic Factor) for an adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cryoprecipitate Dosing for Adults

The recommended adult dose of cryoprecipitate is two pools (10 units total), which provides approximately 4 grams of fibrinogen, administered as rapidly as possible through a standard blood giving set with a 170-200 μm filter. 1

Standard Dosing Protocol

Initial Dose

  • Two pools of cryoprecipitate (equivalent to 10 single units) is the standard adult dose 1, 2
  • Each pool contains 5 units with at least 2 grams of fibrinogen 1
  • Total volume: 100-200 mL per pool 1
  • Each single unit contains 400-450 mg of fibrinogen 1

Alternative Weight-Based Dosing

  • 50 mg/kg of cryoprecipitate (approximately 15-20 units in a 70-kg adult) is recommended in major trauma and bleeding scenarios 1, 3
  • This higher dose aligns with European trauma guidelines for severe hemorrhage 1

Administration Guidelines

Practical Considerations

  • Transfuse using a standard blood giving set with a 170-200 μm filter 1, 2
  • Once thawed, cryoprecipitate must be used within 4 hours 1, 2
  • Do not refrigerate after thawing 1, 2
  • Infuse as rapidly as possible, ideally within 90 minutes of hospital arrival in trauma settings 4
  • ABO compatibility is preferred when possible 5

Clinical Context for Dosing

Fibrinogen Targets

The dose should achieve specific fibrinogen thresholds based on clinical scenario:

  • Major hemorrhage/trauma: Maintain fibrinogen >1.5 g/L 1, 3
  • Obstetric hemorrhage: Maintain fibrinogen >2.0 g/L 1, 3
  • DIC with bleeding: Treat when fibrinogen <1.0 g/L 1
  • Advanced liver disease: Maintain fibrinogen >1.0 g/L 1

Expected Fibrinogen Response

  • A dose of 8-10 units increases fibrinogen by approximately 0.55 g/L (0.06 g/L per unit) 6
  • In cardiac surgery patients, 13.2 mg/kg is required to increase FIBTEM A10 by 1 mm 7
  • In vivo recovery of fibrinogen is approximately 60%, considerably below 100% 7

Repeat Dosing Strategy

When to Redose

  • Repeat doses should be guided by laboratory fibrinogen levels or thromboelastometry (TEG/ROTEM) 1, 3
  • Monitor fibrinogen levels after initial administration 2
  • Additional pools may be needed if target fibrinogen levels are not achieved 1

Monitoring Parameters

  • Check fibrinogen levels 15-60 minutes after administration 5
  • Use viscoelastic testing (TEG/ROTEM) when available to guide therapy 1, 3
  • Serial monitoring every 6-8 hours for 24-48 hours in severe bleeding 5

Important Clinical Caveats

Dosing Variability

The 2016 AAGBI guidelines recommend two pools as standard 1, while European trauma guidelines from 2007-2010 recommend higher doses of 15-20 units (50 mg/kg) for major hemorrhage 1. The higher dose is appropriate for actively bleeding trauma patients, while the lower dose of two pools is suitable for less severe hypofibrinogenemia. 1, 3

Safety Monitoring

  • Monitor for volume overload, particularly in cardiac or renal impairment 2
  • Watch for adverse reactions including anemia (14.3%), acute kidney injury (8.0%), and thrombocytopenia (5.5%) 2
  • Risk of allergic reactions, anaphylaxis, and transfusion-related acute lung injury (TRALI) exists 1, 5

Alternative to Cryoprecipitate

  • Fibrinogen concentrate (3-4 grams IV) may be used instead of cryoprecipitate 1, 3
  • Fibrinogen concentrate offers advantages of standardized dosing, viral inactivation, and no need for cross-matching 3
  • A 4-gram dose of fibrinogen concentrate is considered equivalent to 10 units of cryoprecipitate 8, 9

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.